Trial · NCT02055781
Adverse events573
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 573
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Contusion | Injury, poisoning and procedural complications | Pacritinib, Once Daily | 7 | 104 | 7 |
| other | Contusion | Injury, poisoning and procedural complications | Pacritinib, Twice Daily | 10 | 106 | 10 |
| other | Contusion | Injury, poisoning and procedural complications | Best Available Therapy | 8 | 98 | 8 |
| other | Fall | Injury, poisoning and procedural complications | Pacritinib, Once Daily | 7 | 104 | 7 |
| other | Fall | Injury, poisoning and procedural complications | Pacritinib, Twice Daily | 5 | 106 | 5 |
| other | Fall | Injury, poisoning and procedural complications | Best Available Therapy | 3 | 98 | 3 |
| other | Weight decreased | Investigations | Pacritinib, Once Daily | 4 | 104 | 4 |
| other | Weight decreased | Investigations | Pacritinib, Twice Daily | 7 | 106 | 7 |
| other | Weight decreased | Investigations | Best Available Therapy | 3 | 98 | 3 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Pacritinib, Once Daily | 11 | 104 | 11 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Pacritinib, Twice Daily | 13 | 106 | 13 |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Best Available Therapy | 13 | 98 | 13 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Pacritinib, Once Daily | 11 | 104 | 11 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Pacritinib, Twice Daily | 9 | 106 | 9 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Best Available Therapy | 10 | 98 | 10 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Pacritinib, Once Daily | 9 | 104 | 9 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Pacritinib, Twice Daily | 11 | 106 | 11 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Best Available Therapy | 9 | 98 | 9 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Pacritinib, Once Daily | 34 | 104 | 34 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Pacritinib, Twice Daily | 36 | 106 | 36 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02055781/events